Corticosteroid- and Anabolic Steroid Induced Mental Status Disturbances
Perry
Journal of Pharmacy Practice 2007;20:334-340.
ABSTRACT
A Comparison of Oral Methylprednisolone Plus Azathioprine or Mycophenolate Mofetil for the Treatment of Pemphigus.
Beissert et al.
Arch Dermatol 2006;142:1447-1454.
ABSTRACT
| FULL TEXT
PEMPHIGUS VULGARIS: UPDATE ON ETIOPATHOGENESIS, ORAL MANIFESTATIONS, AND MANAGEMENT
Scully and Challacombe
CROBM 2002;13:397-408.
ABSTRACT
| FULL TEXT
ORAL PEMPHIGUS VULGARIS PRECEDING CUTANEOUS LESIONS: RECOGNITION AND DIAGNOSIS
SIROIS et al.
Journal of the American Dental Association 2000;131:1156-1160.
ABSTRACT
| FULL TEXT
Pemphigus vulgaris in pregnancy: a case report and review of literature
Fainaru et al.
Hum Reprod 2000;15:1195-1197.
ABSTRACT
| FULL TEXT
Pulse Intravenous Cyclophosphamide Therapy in Pemphigus
Fleischli et al.
Arch Dermatol 1999;135:57-61.
ABSTRACT
| FULL TEXT
Therapy of Pemphigus Vulgaris
Stanley
Arch Dermatol 1999;135:76-78.
FULL TEXT
The Pathophysiological Significance of Nondesmoglein Targets of Pemphigus Autoimmunity: Development of Antibodies Against Keratinocyte Cholinergic Receptors in Patients With Pemphigus Vulgaris and Pemphigus Foliaceus
Nguyen et al.
Arch Dermatol 1998;134:971-980.
ABSTRACT
| FULL TEXT
Treatment of Pemphigus Vulgaris With Brief, High-Dose Intravenous Glucocorticoids
Werth
Arch Dermatol 1996;132:1435-1439.
ABSTRACT
The Adjuvant Therapy of Pemphigus: An Update
Bystryn and Steinman
Arch Dermatol 1996;132:203-212.
ABSTRACT
Management of Acquired Bullous Skin Diseases
Fine
NEJM 1995;333:1475-1484.
FULL TEXT
Superficial Erosions With Some Oozing and Marked Crusting
Deloach-Banta and Tenaro
Arch Dermatol 1993;129:633-634.
ABSTRACT
Treatment of Pemphigus Vulgaris With Pulse Intravenous Cyclophosphamide
Pandya and Sontheimer
Arch Dermatol 1992;128:1626-1630.
ABSTRACT
Synchronization of Plasmapheresis and Pulse Cyclophosphamide Therapy in Pemphigus Vulgaris
Euler et al.
Arch Dermatol 1987;123:1205-1210.
ABSTRACT
Dapsone as Initial Treatment in Superficial Pemphigus: Report of Nine Cases
Basset et al.
Arch Dermatol 1987;123:783-785.
ABSTRACT
Adjuvant Therapy of Pemphigus
Bystryn
Arch Dermatol 1984;120:941-951.
ABSTRACT
Vesiculobullous Skin Diseases With Prominent Immunologic Feature
Zweiman and Millikan
JAMA 1982;248:2623-2626.
ABSTRACT
Pemphigus Vulgaris of the Esophagus
WOOD et al.
ANN INTERN MED 1982;96:189-191.
ABSTRACT
Side Effects of Corticosteroid Therapy: Psychiatric Aspects
Ling et al.
Arch Gen Psychiatry 1981;38:471-477.
ABSTRACT
Pemphigus: Current Concepts
AHMED et al.
ANN INTERN MED 1980;92:396-405.
ABSTRACT
Dermatology: An Annotated Bibliography of Recent Literature: References to Journal Articles and Other Papers
DERMATOLOGY COMMITTEE
ANN INTERN MED 1979;91:804-805.
ABSTRACT
Fate of Pemphigus Antibody Following Successful Therapy: Preliminary Evaluation of Pemphigus Antibody Determinations to Regulate Therapy
O'Loughlin et al.
Arch Dermatol 1978;114:1769-1772.
ABSTRACT
Immunosuppressants and Prednisone in Pemphigus Vulgaris: Therapeutic Results Obtained in 63 Patients Between 1961 and 1975
Lever and Schaumburg-Lever
Arch Dermatol 1977;113:1236-1241.
ABSTRACT
Photochemotherapy in Erythrodermic Seborrhoic Dermatitis
Dahl and Reymann
Arch Dermatol 1977;113:1295-1296.
ABSTRACT
Pemphigus Vulgaris Antibody Identifies Pemphaxin. A NOVEL KERATINOCYTE ANNEXIN-LIKE MOLECULE BINDING ACETYLCHOLINE
Nguyen et al.
J. Biol. Chem. 2000;275:29466-29476.
ABSTRACT
| FULL TEXT
We review 107 consecutive cases of pemphigus. The mortality for pemphigus vulgaris and pemphigus vegetans was 46% between 1949 and 1959 and 24% between 1960 and 1970. The overall mortality for all types of pemphigus was 32%. In the corticosteroid era, complications of therapy were the most frequent causes of death. Mortality and morbidity closely correlated with the corticosteroid dosage used to attain control. This dosage proved to be variable and could not be predicted at the outset in any given patient.